Abstract
Onset of action of antisecretory agents is of pivotal importance for patients with gastroesophageal reflux disease (GERD) treated “on-demand.” Aim To study the acute effect of acid-inhibiting drugs and water administration on gastric pH. Method A cross-over study was performed in 12 H. pylori (-), healthy subjects (6 men; mean age: 26 years). A single oral dose of the following agents was received with a wash-out period between each study: a glass of water (200 ml), antacid, ranitidine, omeprazole, esomeprazole, and rabeprazole. Gastric pH was recorded for 6 h after drug intake. Results Water increased gastric pH >4 in 10/12 subjects after 1 min. The time (median) needed to pH >4 was for: antacid 2 min, ranitidine 50 min, omeprazole 171 min, esomeprazole 151 min, and rabeprazole 175 min. Gastric pH >4 lasted for 3 min after water and for 12 min after antacids; it remained >4 until the end of recording in: 4/12 subjects with ranitidine, 11/12 with rabeprazole, and all with omeprazole and esomeprazole. Conclusion Water and antacid immediately increased gastric pH, while PPIs showed a delayed but prolonged effect compared to ranitidine.
Similar content being viewed by others
References
Kennedy T, Jones R (2000) The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 14:1589–1589. doi:10.1046/j.1365-2036.2000.00884.x
Jacobson BC, Ferris TG, Shea TL et al (2003) Who is using chronic acid suppression therapy and why? Am J Gastroenterol 98:51–58. doi:10.1111/j.1572-0241.2003.07186.x
Fass R, Fennerty MB, Vakil N (2001) Nonerosive reflux disease-current concepts and dilemmas. Am J Gastroenterol 96:303–314
Carlson R, Dent J et al (1998) Gastro-esophageal reflux disease (GORD) in primary care- an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 10:119–124. doi:10.1097/00042737-199802000-00004
Tytgat GNJ, Blum AL, Verlinden M (1995) Prognostic factors for relapse and maintenance treatment with cisapride in gastro-esophageal reflux disease. Aliment Pharmacol Ther 9:271–280
Goh KL (2006) “On-demand” therapy for gastroesophageal reflux disease: are current proton pump inhibitors good candidates? J Gastroentrol Hepatol 21(Suppl 5):S115–S118. doi:10.1111/j.1440-1746.2006.04714.x
Hatlebakk JG, Berstad A (1996) Pharmacokinetic optimization in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet 31:386–406
Bell NJ, Burget D, Howden CW et al (1992) Appropriate acid suppression for management of gastro-oesophageal reflux disease. Digestion 51(Suppl 1):59–67
Hurlimann S, Abbuhl B, Inauen W et al (1994) Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 8:193–201
Arnestad JS, Klevemand PM, Waldum HL (1997) In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity. Aliment Pharmacol Ther 11:355–358. doi:10.1046/j.1365-2036.1997.300000.x
Inamori M, Towaga JI, Iwasaki T et al (2005) Early effects of lafutidine or rabeprazole on intragastric acididty: which drug is more suitable for on-demand use? J Gastroenterol 40:453–458. doi:10.1007/s00535-005-1569-0
Khoury RM, Katz PO, Castell DO (1999) Post-pradial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy subjects. Aliment Pharmacol Ther 1211–1214. doi:10.1046/j.1365-2036.1999.00587.x
Robinson M (2001) New generation proton pump inhibitors: overcoming the limitations of early-generation agents. Eur J Gastroenterol Hepatol 13(Suppl 1):S43–S47
Hedenstrom H, Alm C, Kraft M, Grahnen A (1997) Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Aliment Pharmacol Ther 11:1137–1141. doi:10.1046/j.1365-2036.1997.00264.x
Chassany O, Bergmann JF, Simoneau G et al (1996) The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH. Curr Ther Res 57:159–169. doi:10.1016/S0011-393X(96)80121-4
Abe Y, Inamori M, Togawa J et al (2004) The comperative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J Gastroenterol 39:21–25. doi:10.1007/s00535-003-1286-5
Pantoflickova D, Dorta G, Ravic M et al (2003) Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther 17:1507–1514. doi:10.1046/j.1365-2036.2003.01496.x
Zacny J, Zamakhshary M, Skertis I, Veldhuyzen van Zanten S (2005) Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 21:1299–1312. doi:10.1111/j.1365-2036.2005.02490.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karamanolis, G., Theofanidou, I., Yiasemidou, M. et al. A Glass of Water Immediately Increases Gastric pH in Healthy Subjects. Dig Dis Sci 53, 3128–3132 (2008). https://doi.org/10.1007/s10620-008-0301-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0301-3